Hikma Pharmaceuticals Share Price (HIK)

1,393.00 -2.00 (-0.14%) delayed: 11:34AM BST
Bid price 1,392.00 Open price 1,398.00
Ask price 1,394.00 Prev close 1,395.00
High price 1,404.34 Spread 0.14%
Low price 1,380.67 Volume 95,995

Register now for FREE live Hikma Pharmaceuticals share prices, Hikma Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Hikma Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Hikma Pharmaceuticals (HIK) and other London Stock Exchange equities.

Hikma Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Hikma Pharmaceuticals share price charts

Hikma Pharmaceuticals Share Price Information

Name Hikma Pharmaceuticals Epic HIK
Sector Pharmaceuticals & Biotechnology ISIN GB00B0LCW083
Activites Hima Pharmaceuticals plc is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Index FTSE 250

Hikma Pharmaceuticals Key Numbers

Latest Share Price (p) 1,393.00 Net Gearing (%) 41.19
Market Capitalisation (£m) 3,357.03 Gross Gearing (%) 44.74
Shares in issue (m) 240.65 Debt Ratio 30.02
P/E Ratio 20.98 Debt-to-Equity Ratio 0.53
Total dividends per share (p) 33.00 Assets / Equity Ratio 1.81
Dividend Yield (%) 1.52 Price to book value 1.39
Dividend cover (x) 2.02 ROCE (%) 6.10
Earning per share (p) 66.50 EPS Growth (%) -47.47
52 week high / low 2,703.00 / 1,340.00 DPS Growth (%) 3.13

Hikma Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
31/05/2017 TIN Mazen Darwazah ED 38,088
31/05/2017 TIN Said Darwazah CH 52,164
15/05/2017 TIN Mazen Darwazah ED 30,000
15/05/2017 TIN Said Darwazah CH 41,000
20/12/2016 BUY Ali Al-Husry NED 140,730

More Hikma Pharmaceuticals Director Deals >>

Hikma Pharmaceuticals Company News

10:53 24/07/2017

Holding(s) in Company

RNS Number : 8851L Hikma Pharmaceuticals Plc 24 July 2017   Notification of major interests in shares   LONDON, 24 July 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast-growing multinational pharmaceuticals group, announces as follows:...

11:02 04/07/2017

Total Voting Rights

RNS Number : 0660K Hikma Pharmaceuticals Plc 04 July 2017             Hikma Pharmaceuticals PLC Total Voting Rights and Capital   LONDON, 4 July 2017, Hikma Pharmaceuticals PLC (LEI: 549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK)...

15:03 03/07/2017

Holding(s) in Company

RNS Number : 9623J Hikma Pharmaceuticals Plc 03 July 2017     Notification of major interests in shares   LONDON, 3 July 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals group, announces as follows:...

More Hikma Pharmaceuticals Company News >>

Register now for FREE Hikma Pharmaceuticals company news

Hikma Pharmaceuticals Share Price Discussions

more than 1 year ago

Hikma Pharmaceuticals (HIK)

Floated in London last November at 290p (FTSE-250). Company website www.hikma.com Develops, manufactures and markets branded and non-branded generic pharmaceuticals, as well as in-licensed, patented pharmaceuticals Geographic markets: USA, Europe and the Middle East & North Africa...

Register now for FREE Hikma Pharmaceuticals share price discussions